Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Phase of Trial: Phase III
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Raltegravir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016.